Advertisement

ADVERTISEMENT

Videos

Aaron Gerds, MD
Videos
Examining Luspatercept Efficacy for Anemia and Transfusion Burden Among Patients With Myelofibrosis
06/24/2024
Aaron Gerds, MD, presents insights into data from a study in which luspatercept improved anemia and transfusion burden for patients with myelofibrosis, and explains next steps for investigating luspatercept in further clinical trials.
Aaron Gerds, MD, presents insights into data from a study in which luspatercept improved anemia and transfusion burden for patients with myelofibrosis, and explains next steps for investigating luspatercept in further clinical trials.
Aaron Gerds, MD, presents...
06/24/2024
Oncology
Curious about mastering EKG interpretations? In our latest video, we sit down with EKG expert Bob Page, who shares some of his top tips and insights. Don't miss out on his invaluable advice!
Videos
Pediatric Video Tutorial: Lead Placement Pitfalls from an EKG Expert
06/21/2024
Scott DeBoer sits down with EKG expert Bob Page, who shares some of his top tips and insights. Don't miss out on his invaluable advice!
Scott DeBoer sits down with EKG expert Bob Page, who shares some of his top tips and insights. Don't miss out on his invaluable advice!
Scott DeBoer sits down with EKG...
06/21/2024
EMSWorld
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy With Andrew Penn, MS, PMHNP
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
06/21/2024
Psych Congress Network
Erika Hamilton, MD, Sarah Cannon Research Institute
Videos
Trastuzumab Deruxtecan Maintains Superiority Over Trastuzumab Emtansine Among Patients With HER2-Positive Metastatic Breast Cancer
06/20/2024
Erika Hamilton, MD
Erika Hamilton, MD discusses the long-term analysis from the phase 3 DESTINY-Breast03 trial which reinforced the superiority of trastuzumab deruxtecan over trastuzumab emtansine for patients with HER2-positive metastatic breast cancer...
Erika Hamilton, MD discusses the long-term analysis from the phase 3 DESTINY-Breast03 trial which reinforced the superiority of trastuzumab deruxtecan over trastuzumab emtansine for patients with HER2-positive metastatic breast cancer...
Erika Hamilton, MD discusses the...
06/20/2024
Oncology
Nataliya Uboha, MD, PhD
Conference Coverage
Cytoreductive Surgery Plus HIPEC for Patients With Gastric Cancers That Have Limited Peritoneal Carcinomatosis
06/20/2024
Nataliya Uboha, MD, PhD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in...
06/20/2024
Oncology
Reshma Mahtani, DO; Terry Mamounas, MD; Jane Meisel, MD
Videos
Pertuzumab Plus Trastuzumab for Early-Stage HER2-Positive Breast Cancer
06/20/2024
Reshma Mahtani, DO
Terry Mamounas, MD
Jane Meisel, MD
In this video, a panel of experts highlight 8-year updated results from the APHINITY trial and reflect on the progress that has been made in the setting of HER2-positive breast cancer.
In this video, a panel of experts highlight 8-year updated results from the APHINITY trial and reflect on the progress that has been made in the setting of HER2-positive breast cancer.
In this video, a panel of...
06/20/2024
Oncology
Reshma Mahtani, DO; Terry Mamounas, MD; Jane Meisel, MD
Videos
Optimizing Treatment for Patients With High-Risk HER2-Positive Breast Cancer
06/20/2024
Reshma Mahtani, DO
Terry Mamounas, MD
Jane Meisel, MD
In this video, our experts explore therapy options for patients with high-risk HER2-positive breast cancer, sharing their views on anthracycline-based therapies, neratinib, and immunotherapy for these patients, and discussing data from the...
In this video, our experts explore therapy options for patients with high-risk HER2-positive breast cancer, sharing their views on anthracycline-based therapies, neratinib, and immunotherapy for these patients, and discussing data from the...
In this video, our experts...
06/20/2024
Oncology
Reshma Mahtani, DO; Terry Mamounas, MD; Jane Meisel, MD
Videos
Managing Patients With Stage 1 HER2-Positive Breast Cancer
06/20/2024
Reshma Mahtani, DO
Terry Mamounas, MD
Jane Meisel, MD
In this video, a panel of experts discuss the management of patients with stage 1, HER2-positive breast cancer, sharing data from several trials in this space, including the APT, ADEPT, and ATEMPT 2.0 trials.
In this video, a panel of experts discuss the management of patients with stage 1, HER2-positive breast cancer, sharing data from several trials in this space, including the APT, ADEPT, and ATEMPT 2.0 trials.
In this video, a panel of...
06/20/2024
Oncology
Nataliya Uboha, MD, PhD
Conference Coverage
Role of Immunotherapy for Patients With Microsatellite Instability
06/20/2024
Nataliya Uboha, MD, PhD
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in...
06/20/2024
Oncology
Reshma Mahtani, DO, Terry Mamounas, MD, Jane Meisel, MD
Videos
Neoadjuvant vs Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer
06/20/2024
Reshma Mahtani, DO
Terry Mamounas, MD
Jane Meisel, MD
In this video, a panel of experts discuss approaches to neoadjuvant and adjuvant therapy for early-stage HER2-positive breast cancer and the value of achieving a pathological complete response from the surgical and medical oncology...
In this video, a panel of experts discuss approaches to neoadjuvant and adjuvant therapy for early-stage HER2-positive breast cancer and the value of achieving a pathological complete response from the surgical and medical oncology...
In this video, a panel of...
06/20/2024
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use